Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1997-05-29
1999-11-30
Caputa, Anthony C.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 701, 435 711, 4352523, 4353201, 435325, 536 235, C12P 2106, C12N 120, C12N 1500, C07H 2104
Patent
active
059941006
ABSTRACT:
HOEFC11 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing HOEFC11 polypeptides and polynucleotides in the design of protocols for the treatment of chronic renal failure, inflammatory diseases, myocardial ischemia, cancer, rheumatoid arthritis, cirrhotic liver disease, among others, and diagnostic assays for such conditions.
REFERENCES:
Watanabe et al., "Molecular Identification of a Putative Human Hyaluronan Synthase*", The Journal of Biological Chemistry, vol. 271, No. 38, pp. 22945-22948, Sep. 1996.
Itano et al., "Molecular Cloning of Human Hyaluronan Synthase.sup.1 ", Biochemical and Biophysical Research Communications, vol. 222, pp. 816-820, (1996).
Brecht et al., "Increased hyaluronate synthesis is required for fibroblast detachment and mitosis", Biochem. J., vol. 239, p. 445-450, (1986).
Matuoka et al., "Hyaluronate Synthetase Inhibition by Normal and Transformed Human Fiborblasts during Growth Reduction", The Journal of Cell Biology, vol. 104, pp. 1105-1115, Apr. 1987.
Kitchen et al., "Synthesis and release of hyaluronic acid by Swiss 3T3 fibroblasts", Biochem J., vol. 309, pp. 649-656 (1995).
Lazar et al (Molecular & Cellular Biology vol. 8, No.3, Mar. 1988 pp. 1247-1252).
Burgess et al (Journal of Cell Biology vol. III, 1990 pp. 2129-2138).
Salgaller et al (Cancer Immunol. Immunother. vol. 39 1994 pp. 105-116).
Kumar et al (Journal of Bone & Mineral Research, vol. 8 No. 4, Apr. 1993 pp. 505-513).
Nambi Ponnal
Pullen Mark A
Zhu Yuan
Caputa Anthony C.
Hecht Elizabeth J.
King William T.
Navarro Mark
SmithKline Beecham Corporation
LandOfFree
HAS2 splicing variant HOEFC11: a target in chronic renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HAS2 splicing variant HOEFC11: a target in chronic renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HAS2 splicing variant HOEFC11: a target in chronic renal failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1670446